Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilda Barliya

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Plos One|September 28, 2011
Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapyTilda Barliya, Mathilda Mandel, Tami Livnat, et al.
Indian Journal of Ophthalmology|January 31, 2018
Transcleral approach for closing retinal tears using DuraSeal™ hydrogel sealantTilda Barliya, Shai Sandalon, Ron Ofri, et al.
Journal of Ophthalmology|May 12, 2017
Changes in Retinal Function and Cellular Remodeling Following Experimental Retinal Detachment in a Rabbit ModelTilda Barliya, Ron Ofri, Shai Sandalon, et al.
Advanced Drug Delivery Reviews|January 18, 2019
T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancerVasyl Eisenberg, Shiran Hoogi, Astar Shamul, et al.
Cornea|March 30, 2013
Remote manipulation of posterior lamellar corneal grafts using a magnetic fieldYoav Nahum, Tilda Barliya, Irit Bahar, et al.
Journal for Immunotherapy of Cancer|September 11, 2019
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor functionShiran Hoogi, Vasyl Eisenberg, Shimrit Mayer, et al.
Molecular Carcinogenesis|May 12, 2020
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cellsSara Meril, Ortal Harush, Yishai Reboh, et al.
Angiogenesis|September 1, 2005
Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applicationsGad Lavie, Mathilda Mandel, Sadick Hazan, et al.
Immunology|September 11, 2009
Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signaturesMathilda Mandel, Anat Achiron, Tamir Tuller, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 25, 2017
Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse ModelMichal Schaap-Fogler, Irit Bahar, Ada Rephaeli, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Plos One|September 28, 2011
Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapyTilda Barliya, Mathilda Mandel, Tami Livnat, et al.
Indian Journal of Ophthalmology|January 31, 2018
Transcleral approach for closing retinal tears using DuraSeal™ hydrogel sealantTilda Barliya, Shai Sandalon, Ron Ofri, et al.
Journal of Ophthalmology|May 12, 2017
Changes in Retinal Function and Cellular Remodeling Following Experimental Retinal Detachment in a Rabbit ModelTilda Barliya, Ron Ofri, Shai Sandalon, et al.
Advanced Drug Delivery Reviews|January 18, 2019
T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancerVasyl Eisenberg, Shiran Hoogi, Astar Shamul, et al.
Cornea|March 30, 2013
Remote manipulation of posterior lamellar corneal grafts using a magnetic fieldYoav Nahum, Tilda Barliya, Irit Bahar, et al.
Journal for Immunotherapy of Cancer|September 11, 2019
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor functionShiran Hoogi, Vasyl Eisenberg, Shimrit Mayer, et al.
Molecular Carcinogenesis|May 12, 2020
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cellsSara Meril, Ortal Harush, Yishai Reboh, et al.
Angiogenesis|September 1, 2005
Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applicationsGad Lavie, Mathilda Mandel, Sadick Hazan, et al.
Immunology|September 11, 2009
Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signaturesMathilda Mandel, Anat Achiron, Tamir Tuller, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 25, 2017
Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse ModelMichal Schaap-Fogler, Irit Bahar, Ada Rephaeli, et al.
Pageof 2